W Müller-Felber

Author PubWeight™ 32.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 2009 1.90
2 Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1999 1.60
3 Inflammatory demyelinating neuropathy in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis (CAPD) Perit Dial Int 1998 1.43
4 High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study. J Neurol 2000 1.30
5 Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab 2007 1.29
6 Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients. Neurology 2003 1.24
7 FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet 2004 1.24
8 Consequences of mutations within the C terminus of the FHL1 gene. Neurology 2009 1.18
9 Borrelia burgdorferi myositis: report of eight patients. J Neurol 1993 1.05
10 Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 2007 0.98
11 A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin. Neurology 1999 0.97
12 Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology 2000 0.94
13 Muscular ultrasound in idiopathic inflammatory myopathies of adults. J Neurol Sci 1993 0.93
14 Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations. Neurology 2006 0.91
15 A placebo-controlled crossover trial of creatine in mitochondrial diseases. Neurology 2000 0.91
16 Changes of sonographic, magnetic resonance tomographic, electromyographic, and histopathologic findings within a 2-month period of examinations after experimental muscle denervation. Arch Orthop Trauma Surg 1998 0.90
17 Noninvasive (13)C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion 2000 0.88
18 [Quality of life after brachial plexus lesions in adults]. Handchir Mikrochir Plast Chir 2013 0.84
19 Metabolic control and effect on secondary complications of diabetes mellitus by pancreatic transplantation. Baillieres Clin Gastroenterol 1989 0.84
20 Markedly different course of Friedreich's ataxia in sib pairs with similar GAA repeat expansions in the frataxin gene. Acta Neuropathol 1999 0.82
21 Genetic identity of Marinesco-Sjögren/myoglobinuria and CCFDN syndromes. Neurology 2002 0.82
22 Prediction of response to IVIg treatment in patients with lower motor neurone disorders. Eur J Neurol 2006 0.81
23 Myofibrillogenesis in primary tissue cultures of adult human skeletal muscle: expression of desmin, titin, and nebulin. Clin Investig 1994 0.81
24 Early white matter changes in childhood multiple sclerosis: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2013 0.79
25 Phenotypic variability in two brothers with sarcotubular myopathy. J Neurol 1999 0.79
26 Heterozygotic gene expression in endomyocardial biopsies: a new diagnostic tool confirms the Duchenne carrier status. Clin Investig 1993 0.78
27 [Splints in birth-related brachial plexus injuries]. Handchir Mikrochir Plast Chir 2011 0.78
28 Chronic myopathy in a patient suspected of carrying two malignant hyperthermia susceptibility (MHS) mutations. Neuromuscul Disord 1992 0.77
29 [Intestinal pseudoobstructions and gastric necrosis in mitochondrial myopathy]. Dtsch Med Wochenschr 2002 0.77
30 Mitochondrial DNA depletion and fatal infantile hepatic failure due to mutations in the mitochondrial polymerase γ (POLG) gene: a combined morphological/enzyme histochemical and immunocytochemical/biochemical and molecular genetic study. J Cell Mol Med 2011 0.77
31 Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur J Med Res 1997 0.76
32 [Neuromuscular complications after allogeneic bone marrow transplantation]. Nervenarzt 2003 0.76
33 Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies). Clin Neurol Neurosurg 1999 0.76
34 Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood. Acta Myol 2004 0.76
35 Localization of transforming growth factor beta in association with neuromuscular junctions in adult human muscle. Cell Mol Neurobiol 1999 0.75
36 Drug-induced systemic lupus erythematosus after 8 years of treatment with carbamazepine. Eur J Clin Pharmacol 1998 0.75
37 [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?]. Nervenarzt 1994 0.75
38 [Paraneoplastic myopathies]. Internist (Berl) 1990 0.75
39 Clindamycin and nicotinic neuromuscular transmission. Lancet 1999 0.75
40 Upregulation of utrophin in the myocardium of a carrier of Duchenne muscular dystrophy. Eur Heart J 1997 0.75
41 [A paranoid syndrome after discontinuing tuberculostatics]. Dtsch Med Wochenschr 1991 0.75
42 Congenital myasthenic syndromes: clinical and genetic analysis of 18 patients. Eur J Med Res 1997 0.75
43 [Muscular pain]. Internist (Berl) 1990 0.75
44 Successful treatment of muscle sarcoidosis with thalidomide. Acta Myol 2003 0.75
45 Extracorporeal antibody elimination in neuroimmunological diseases. Ther Apher 1999 0.75
46 Successful management of polyneuropathy associated with IgM gammopathy of undetermined significance with antibody-based immunoadsorption. Clin Nephrol 2000 0.75
47 Duct occlusion-induced vascularized islet grafts are not associated with progressive long-term dysfunction. Transplant Proc 1995 0.75
48 [Pancreas transplantation in Type I diabetic patients]. Fortschr Med 1990 0.75
49 Cross-sectional study of peripheral microcirculation in diabetic patients with microangiopathy: influence of pancreatic and kidney transplantation. Acta Diabetol 1993 0.75
50 [New insights in pathogenesis and therapy of sporadic inclusion body myositis (s-IBM)]. Nervenarzt 2001 0.75
51 [50-year-old patient with rapid ataxia onset, generalized paresthesia and myoclonus]. Internist (Berl) 1997 0.75